IPOs With Potential...
Health Care: Drugs
PDL BioPharma Inc. (PDLI: NASDAQ)
$6.48 0.00 | 0.08%
02/08/12 - 04:00 PM ET
2.54M / 2.19M
Vol / Avg. Vol:6.53 / 6.48
Open / Prev. Close:6.42 - 6.53
Today's Range:4.66 - 6.70
52 Wk Range:4.60%
Performance YTD:TheStreet Rating:
Portfolios with PDLI
- Portfolio NameUser Type
- ContributorHighest-Yielding Drug Stocks
- ProSeth Klarman - Baupost Group
- UserDividend
- Contributor18 Fundamentally Strong Sto...
- UserGK13
- UserMy current
- ContributorBreakout Stocks Of The Week...
- UserPortfolio 1
- Contributor6 Stocks That Could Double ...
- Usercurrent
Latest PDLI Headlines from TheStreet
- PDL BioPharma's CEO Presents At 30th Annual JP Morgan Healthcare Conference (Transcript) 01.12.12 | 06:01 pm
- Stocks to Watch: Vulcan, Zynga, Winn-Dixie (Update 2) 12.19.11 | 08:12 am
- PDL BioPharma Stock To Go Ex-dividend Tomorrow (PDLI) 12.05.11 | 09:12 am
- PDL BioPharma Inc. Stock Upgraded (PDLI) 11.16.11 | 05:11 am
- Hedge Fund 13F Stock Picks: Profiting From Idea Season 11.15.11 | 12:11 pm
- PDL BioPharma's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.09.11 | 09:11 pm
- 3 Stocks I Saw on TV, September 27
09.27.11 | 08:09 am - PDL BioPharma Stock To Go Ex-dividend Tuesday (PDLI) 09.02.11 | 10:09 am
- PDL BioPharma Inc. Stock Downgraded (PDLI) 08.01.11 | 08:08 am
- PDL Biopharma's CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.27.11 | 08:07 pm
Press Releases for PDLI
- PDL BioPharma To Present At The 14th Annual BIO CEO & Investor Conference - PR Newswire 02.07.12 | 07:02 am
- PDL BioPharma Announces Exchange Of Its 2.875% Convertible Senior Notes Due February 15, 2015 - PR Newswire 02.02.12 | 05:02 pm
- PDL BioPharma Announces Settlement And Final Results Of Its Exchange Offer - PR Newswire 01.05.12 | 08:01 pm
- PDL BioPharma To Present At The 30th Annual JP Morgan Healthcare Conference - PR Newswire 01.05.12 | 07:01 am
- PDL BioPharma Announces Expiration And Preliminary Results Of Its Exchange Offer - PR Newswire 01.03.12 | 06:01 pm
- PDL BioPharma Completes Regular Quarterly Dividend Payment - PR Newswire 12.15.11 | 07:12 am
- PDL BioPharma Announces Departure Of Chief Financial Officer - PR Newswire 12.12.11 | 07:12 am
- PDL BioPharma Corrects Its Adjusted Conversion Rates For Its Convertible Notes - PR Newswire 12.12.11 | 07:12 am
- PDL BioPharma Announces Adjusted Conversion Rates For Its Convertible Notes - PR Newswire 12.07.11 | 07:12 am
- PDL BioPharma Inc. Announces Exchange Offer For Its 2.875% Convertible Senior Notes Due February 15, 2015 - PR Newswire 11.15.11 | 07:11 am
Partner Headlines for PDLI
- 7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows - Seeking Alpha 02.03.12 | 07:02 pm
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- 8 Names Yielding Over 9%: A Look At Their Hedging Costs - Seeking Alpha 01.01.12 | 08:01 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- Positioning Your Equity Portfolio For High Yield With Moderate Risk, Part III - Seeking Alpha 11.20.11 | 08:11 am
- Dogs Of The 3x9 Sectors Index Update For November - Seeking Alpha 11.17.11 | 09:11 am
- 10 Oversold, Profitable Small Caps With Great Upside Potential - Seeking Alpha 10.26.11 | 09:10 am
- 10 Market Selected Sector Dividend Buy Opportunities: Dogs Of The Index Q4 Update - Seeking Alpha 10.24.11 | 09:10 am
- Tracking Seth Klarman's Baupost Group Holdings - Seeking Alpha 10.18.11 | 09:10 am
- Dogs Of The Indices In Depth Part 1: The High Yielding Russell Index Dogs - Seeking Alpha 09.16.11 | 07:09 am
